DOCELIEVA 80 MG (Docetaxel Injection IP 80 mg) is a prescription anticancer medicine containing Docetaxel 80 mg, a chemotherapy agent belonging to the Taxane class of anticancer drugs. Docetaxel is widely used in the treatment of various cancers by disrupting cancer cell division and slowing tumor growth.

Docetaxel works by stabilizing microtubules inside cancer cells, preventing their normal breakdown during mitosis (cell division). This action inhibits cancer cell replication and ultimately leads to cancer cell death. Due to its established efficacy, Docetaxel is an important component of many oncology treatment protocols worldwide.

DOCELIEVA 80 MG is commonly prescribed for the treatment of breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric cancer, and head and neck cancers. It may be administered as a single-agent therapy or in combination with other anticancer medicines depending on the patient's treatment plan.

The 80 mg strength offers flexibility for individualized dosing based on body surface area (BSA), treatment protocols, and clinical requirements.

The medicine is administered intravenously under the supervision of qualified healthcare professionals experienced in oncology treatment.

DOCELIEVA 80 MG is commonly used for:

• Breast Cancer
• Non-Small Cell Lung Cancer (NSCLC)
• Metastatic Prostate Cancer
• Gastric Cancer
• Head and Neck Cancer
• Advanced Solid Tumors
• Combination Chemotherapy Programs
• Oncology Treatment Protocols

Manufactured according to stringent pharmaceutical quality standards, DOCELIEVA 80 MG is designed to provide consistent quality, safety, and therapeutic effectiveness.

Patients receiving Docetaxel therapy require routine monitoring of blood counts, liver function, and overall clinical status throughout treatment.

Due to its broad clinical applications and proven effectiveness, DOCELIEVA 80 MG remains a trusted medicine in modern cancer management.

DOCELIEVA 80 MG (Docetaxel Injection IP 80 mg) is primarily used in the treatment and management of various cancers.

Common Uses of DOCELIEVA 80 MG

1. Breast Cancer

Docetaxel is widely used in early-stage, locally advanced, and metastatic breast cancer treatment.

2. Non-Small Cell Lung Cancer (NSCLC)

The medicine is commonly prescribed as part of chemotherapy regimens for lung cancer.

3. Prostate Cancer

Docetaxel is frequently used in metastatic castration-resistant prostate cancer treatment.

4. Gastric Cancer

The medicine may be incorporated into treatment plans for advanced stomach cancer.

5. Head and Neck Cancer

Doctors may prescribe Docetaxel as part of combination chemotherapy protocols.

6. Advanced Solid Tumors

The medicine is utilized in various oncology treatment programs depending on clinical requirements.

7. Combination Chemotherapy

Docetaxel is often used alongside other anticancer medicines to improve treatment outcomes.

How DOCELIEVA 80 MG Works

Docetaxel belongs to a class of medicines known as Taxane Anticancer Agents.

DOCELIEVA works by:

• Stabilizing microtubules within cancer cells
• Preventing normal cell division
• Blocking mitosis (cell replication)
• Inhibiting tumor growth
• Triggering cancer cell death
• Slowing disease progression

This mechanism helps control cancer development and supports effective disease management.

Like all medicines, DOCELIEVA 80 MG may cause side effects in some patients. The severity and frequency of side effects vary among individuals.

Common Side Effects

1. Low Blood Cell Counts

Reduction in white blood cells, red blood cells, and platelets may occur.

2. Fatigue

Weakness and tiredness are commonly reported.

3. Hair Loss (Alopecia)

Temporary hair loss may occur during treatment.

4. Nausea and Vomiting

Digestive discomfort may develop during therapy.

5. Peripheral Neuropathy

Numbness, tingling, or nerve-related symptoms may occur.

6. Fluid Retention

Some patients may experience swelling in the hands, feet, or legs.

7. Mouth Sores

Inflammation or ulcers inside the mouth may occur.

8. Diarrhea

Digestive disturbances may develop during treatment.

9. Nail Changes

Changes in nail color or texture may be observed.

Serious Side Effects

Seek immediate medical attention if you experience:

• Severe allergic reactions
• Persistent fever
• Serious infections
• Difficulty breathing
• Severe fluid retention
• Significant bleeding or bruising
• Severe neuropathy
• Liver-related complications
• Severe bone marrow suppression

Patients should contact their healthcare provider immediately if serious symptoms occur.

The dosage of DOCELIEVA 80 MG (Docetaxel Injection IP 80 mg) should always be determined by a qualified oncologist.

Factors Affecting Dosage

1. Type of Cancer

Treatment recommendations vary according to the disease being treated.

2. Body Surface Area (BSA)

Dosage is generally calculated according to body surface area.

3. Liver Function

Hepatic function plays an important role in dosage planning.

4. Blood Test Results

Laboratory monitoring helps guide treatment decisions.

5. Combination Therapy

Concurrent anticancer medicines may influence dosage schedules.

Important Dosage Instructions

• The medicine should only be administered by qualified healthcare professionals.
• Follow all scheduled chemotherapy sessions.
• Attend routine blood tests and monitoring appointments.
• Inform your doctor about any unusual symptoms.
• Maintain adequate hydration and nutrition.
• Do not miss oncology follow-up visits.

Precautions Before Using DOCELIEVA 80 MG

Before starting treatment, inform your doctor if you have:

• Liver disease
• Blood disorders
• Active infections
• Peripheral neuropathy
• Previous chemotherapy-related complications
• Allergies to Docetaxel or related medicines

Important Monitoring Requirements

Patients receiving Docetaxel therapy may require:

• Complete blood count monitoring
• Liver function tests
• Clinical evaluations
• Neurological assessments
• Regular oncology follow-ups

Patients should also disclose all prescription medicines, supplements, vitamins, and herbal products they are taking to avoid potential drug interactions.

Pregnant and breastfeeding women should not use this medicine unless specifically advised by a healthcare professional.

Storage Instructions

• Store according to manufacturer recommendations.
• Protect from excessive heat and direct sunlight.
• Keep out of reach of children.
• Handle under appropriate pharmaceutical conditions.

Why Choose DOCELIEVA 80 MG?

• Contains high-quality Docetaxel 80 mg
• Effective taxane-based anticancer therapy
• Widely used in breast, lung, prostate, gastric, and head & neck cancers
• Suitable for individualized and combination chemotherapy regimens
• Manufactured under strict pharmaceutical quality standards
• Reliable therapeutic performance
• Supports modern oncology treatment protocols
• Designed for advanced cancer management

Frequently Asked Questions (FAQs)

What is DOCELIEVA 80 MG used for?

It is used for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, head and neck cancer, and other advanced solid tumors.

What is Docetaxel?

Docetaxel is a taxane-based chemotherapy medicine that prevents cancer cells from dividing and multiplying.

Is DOCELIEVA 80 MG chemotherapy?

Yes. Docetaxel is a widely used chemotherapy agent in oncology.

Does DOCELIEVA 80 MG cause hair loss?

Yes. Temporary hair loss is a common side effect during treatment.

Can DOCELIEVA 80 MG cause nerve-related side effects?

Yes. Peripheral neuropathy, including numbness and tingling in the hands and feet, may occur.

Does DOCELIEVA 80 MG affect blood counts?

Yes. The medicine may lower white blood cells, red blood cells, and platelet counts.

Is monitoring necessary during treatment?

Yes. Regular blood tests and medical evaluations are important throughout therapy.

Should DOCELIEVA 80 MG be administered under medical supervision?

Yes. This medicine should only be administered by qualified healthcare professionals experienced in oncology treatment.